UAE Mammography Market Research Report: Forecast (2026-2032)

UAE Mammography Market Report Key Takeaways:

• The UAE Mammography market size was valued at USD 27.66 million in 2025 and is projected to grow from USD 30.23 million in 2026 to USD 51.45 million by 2032, exhibiting a CAGR of 9.27% during the forecast period.
• By product type, the digital mammography systems segment represented a significant share of about 48% in the UAE Mammography Market in 2026.
• By application, the diagnostic segment seized a significant share of about 55% in the UAE Mammography Market in 2026.
• Leading mammography companies in the UAE are Hologic Inc., Siemens Healthcare LLC, Philips Middle East and Africa FZ-LLC, FUJIFILM Middle East FZE, Carestream Health Inc., Allengers Medical Systems Limited, Trivitron Healthcare Private Limited, Planmed Oy, Metaltronica S.p.A., Genoray Co., Ltd., and Others.

Market Insights & Analysis: UAE Mammography Market (2026-32):

The UAE Mammography Market size was valued at around USD 27.66 million in 2025 and is projected to grow from USD 30.23 million in 2026 to USD 51.45 million by 2032. Along with this, the market is estimated to grow at a CAGR of around 9.27% during the forecast period, i.e., 2026-32.

The UAE Mammography Market is projected to expand steadily, driven by the rising burden of breast cancer cases and the increasing adoption of artificial intelligence in mammography screening, which is enhancing early detection capabilities and improving diagnostic efficiency across healthcare facilities.

Increasing public awareness, improved healthcare infrastructure, and supportive national health initiatives are collectively strengthening the demand for early breast cancer detection services across the country.

Breast cancer remains one of the most prevalent cancers affecting women in the UAE. According to the UAE National Cancer Registry, the breast cancer incidence rate has reached 94 cases per 100,000 women, reflecting the growing prevalence of the disease among the female population.

In 2023, approximately 1,456 new breast cancer cases were diagnosed nationwide, making it one of the most frequently reported cancers in the country. Medical experts have also observed a concerning trend in the region, where breast cancer is often diagnosed 10–15 years earlier than the global average, with some cases occurring among women in their twenties. This early onset highlights the increasing need for regular screening and preventive healthcare initiatives aimed at early detection and timely treatment.

Despite the rising disease burden, the UAE has made significant progress in improving early diagnosis. Expanded screening programs and national awareness campaigns have helped increase participation in preventive health services. As a result, around 66% of breast cancer cases in the UAE are detected at early stages, contributing to survival rates of nearly 98% after diagnosis due to timely treatment and access to advanced healthcare services.

The growing adoption of artificial intelligence in mammography screening is further supporting market growth. AI-enabled diagnostic systems assist radiologists by improving imaging analysis accuracy, identifying subtle abnormalities, and reducing the time required to interpret mammograms. These technologies are particularly valuable as healthcare providers manage increasing screening volumes and seek to enhance diagnostic efficiency.

Future policy initiatives are also expected to accelerate the market’s expansion. In 2026, UAE federal health authorities announced plans to expand mandatory early cancer screening programs nationwide and integrate preventive tests with health insurance requirements, ensuring broader participation in regular health examinations. This initiative is expected to significantly increase the number of women undergoing routine mammography screenings across the country.

National screening guidelines further reinforce preventive care. Women aged 40 and above are encouraged to undergo mammography every two years, while women aged 20–39 are advised to receive clinical breast examinations every three years. Women aged 35–39 may also opt for clinical risk assessments, strengthening early detection strategies within the national healthcare framework.

The rising incidence of breast cancer, increasing integration of AI-powered diagnostic tools, and the government’s expanding screening initiatives are expected to drive sustained demand for mammography services in the UAE. Together, these factors will strengthen early detection capabilities and support the long-term growth of the mammography market.

UAE Mammography Market Recent Developments:

• 2025: A Dubai-based breast clinic, HealthBay Vitalia, introduced an AI-integrated 3D mammography system to enhance breast cancer screening and improve early detection rates. The technology uses Hologic 3Dimensions mammography with Genius AI Detection, which analyzes breast images and helps radiologists identify abnormalities more accurately. The system can detect 20–65% more invasive breast cancers compared with conventional 2D mammography, strengthening diagnostic precision in screening programs .
• 2025: The Burjeel Cancer Institute launched a mobile mammogram truck under the “Scan for Life” initiative to provide free breast cancer screenings across Abu Dhabi, Al Ain, and Al Dhafra. The unit is equipped with high-resolution digital mammography technology and travels to malls, workplaces, and community centers to improve early detection and accessibility.

UAE Mammography Market Recent Scope:

UAE Mammography Market Driver:

Growing Burden of Breast Cancer Cases

The growing burden of breast cancer cases is a major driver supporting the expansion of the UAE mammography market. As the incidence of cancer continues to increase across the country, healthcare authorities are placing greater emphasis on early detection and preventive screening programs, which directly increases the demand for mammography services and advanced diagnostic technologies.

According to the 2023 report of the UAE National Cancer Registry, a total of 7,487 new cancer cases were diagnosed nationwide, including both invasive and in-situ cancers. Among these, breast cancer accounted for approximately 1,445 invasive cases, making it the most common cancer among women in the UAE. The disease represented about 36.6% of all female cancer cases, highlighting the significant burden it places on the national healthcare system.

The registry report shows that breast cancer is the leading cancer type among both Emirati nationals and expatriate residents in the UAE. Notably, 1,128 cases were reported among non-Emirati residents, accounting for 20.7% of invasive cancer diagnoses, highlighting the growing need for accessible screening programs and early diagnostic infrastructure across the country .

The rising number of breast cancer diagnoses is encouraging healthcare providers to expand screening programs, invest in advanced mammography technologies, and strengthen public awareness initiatives aimed at early detection.

The increasing prevalence of breast cancer across both Emirati and expatriate populations is significantly driving the demand for mammography screening. As early detection becomes a national healthcare priority, this rising disease burden will continue to accelerate the growth of the UAE mammography market.

UAE Mammography Market Trend:

Adoption of AI in Mammography Screening

The adoption of artificial intelligence (AI) in mammography screening is becoming a key trend in the UAE healthcare sector. Hospitals are integrating AI-enabled diagnostic platforms to help radiologists analyze mammograms faster and detect abnormalities more accurately, supporting early breast cancer detection as nationwide screening programs and imaging volumes continue to expand.

A major milestone in AI-driven screening was recorded in 2025, when Abu Dhabi Health Services Company (SEHA) entered a five-year agreement with Lunit, a medical AI diagnostics firm, to deploy the Lunit INSIGHT MMG AI mammography analysis platform across its healthcare network. The system is being implemented in 14 hospitals and more than 70 clinics, collectively representing over 3,000 hospital beds, significantly strengthening the emirate’s breast cancer screening infrastructure. Under this program, the AI platform is expected to analyze more than 100,000 mammography images during the contract period, enabling radiologists to identify suspicious lesions and early-stage breast cancer with improved precision while accelerating reporting times.

Such initiatives reflect the UAE’s broader digital health transformation, where AI technologies are increasingly integrated into radiology workflows to enhance screening efficiency and support clinical decision-making.

The integration of AI-powered mammography solutions is transforming breast cancer screening practices in the UAE. As healthcare providers continue investing in AI-based diagnostic platforms, the demand for advanced mammography systems is expected to rise, supporting the sustained growth of the UAE mammography market in the coming years.

UAE Mammography Market Opportunity:

Expansion of Mobile Mammography Units

The expansion of mobile mammography units is emerging as a significant opportunity for the UAE mammography market as healthcare providers increasingly focus on improving access to early breast cancer screening services.

Mobile diagnostic clinics bring mammography screening directly to communities, workplaces, and public locations, improving access for women who cannot easily visit hospitals and increasing participation in preventive breast cancer screening programs.

A notable example of this initiative is the nationwide Pink Caravan campaign organized by Friends of Cancer Patients, which has become one of the UAE’s largest breast cancer awareness and screening programs. In 2024, the campaign deployed more than 100 mobile clinics alongside eight fixed screening centers across the country to provide free breast cancer screening and educational services. These mobile units helped extend screening coverage to multiple emirates and increased public awareness regarding early detection.

The program continued to expand in 2025, delivering 19,527 breast cancer screenings nationwide through mobile and fixed clinics, reflecting strong participation in community-based health initiatives.

The rapid expansion of mobile mammography programs is significantly improving accessibility to breast cancer screening across the UAE. As government campaigns and healthcare providers continue to deploy mobile diagnostic units, the demand for mammography systems and imaging technologies is expected to rise, creating strong growth opportunities for the UAE mammography market.

UAE Mammography Market Challenge:

High Cost of Advanced Mammography Equipment

The high cost of advanced mammography technologies, particularly 3D mammography (digital breast tomosynthesis), remains a notable challenge for the expansion of breast cancer screening services in the UAE. While advanced imaging technologies significantly improve diagnostic accuracy and early tumor detection, the associated costs can limit widespread accessibility.

In the UAE, the price of 3D mammography screening typically ranges between approximately USD 163 and USD 272, depending on the diagnostic center, imaging technology used, and whether additional examinations or consultations are included. These higher costs can discourage routine screening among uninsured individuals or those required to pay out-of-pocket. As a result, some women may delay preventive screenings despite growing national awareness campaigns encouraging early detection.

The cost barrier can also affect healthcare providers. Hospitals and diagnostic centers must invest in expensive imaging equipment, specialized software, and trained radiology professionals to operate advanced mammography systems. These financial requirements may slow the adoption of newer screening technologies, particularly among smaller healthcare facilities or community clinics with limited budgets.

The relatively high price of advanced mammography services can restrict patient participation in regular screenings and slow technology adoption among healthcare providers. Consequently, these financial barriers may limit the expansion of screening infrastructure and restrain overall market growth in the coming years.

UAE Mammography Market (2026-32) Segmentation Analysis:

The UAE Mammography Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2026–32 at the country level. Based on the analysis, the market has been further classified as;

Based on Product Type:

• Analog Mammography Systems
• Digital Mammography Systems
• Breast Tomosynthesis Systems
• Film-Screen Mammography Systems
• Biopsy & Interventional Mammography Systems

The digital mammography systems segment dominates the UAE Mammography market with 48% market share, due to their superior diagnostic capabilities, operational efficiency, and compatibility with modern healthcare technologies.

Compared with conventional analog and film-screen mammography systems, digital mammography enables high-resolution image acquisition and electronic storage, allowing radiologists to review, enhance, and analyze images with greater precision. This capability significantly improves the early detection of small tumors and subtle breast tissue abnormalities.

Another important factor contributing to the dominance of digital mammography systems is their integration with advanced imaging technologies, including artificial intelligence (AI) and computer-aided detection (CAD) tools. These solutions support radiologists in identifying suspicious patterns, reducing interpretation errors, and improving the efficiency of breast cancer screening programs.

The transition toward digital systems is also supported by government initiatives focused on strengthening early cancer detection and expanding national screening programs. Digital mammography allows faster image processing, easier data storage, and seamless sharing of imaging records across healthcare networks, which is essential for large-scale screening and patient monitoring.

Collectively, these advantages have established digital mammography systems as the dominant product segment, supporting more accurate diagnosis, improved clinical workflows, and the continued growth of mammography services across the UAE healthcare sector.

Based on Application:

• Screening
• Diagnostic
• Research
• Therapeutic

The diagnostic segment dominates the UAE Mammography market with 55% market share, primarily due to the increasing demand for detailed breast imaging to evaluate abnormalities detected during routine screenings or clinical examinations.

While screening mammography is designed for preventive assessment among asymptomatic women, diagnostic mammography is essential for further investigation when suspicious findings such as breast lumps, tissue irregularities, or abnormal screening results are identified.

The rising incidence of breast cancer in the UAE has significantly increased the need for accurate diagnostic evaluation. Patients who receive abnormal results from screening programs are typically referred for diagnostic mammography, which provides more comprehensive imaging through additional views and targeted examinations. This approach enables radiologists to closely analyze breast tissue structures and determine whether further diagnostic procedures, including ultrasound, magnetic resonance imaging (MRI), or biopsy, are required.

Technological advancements in breast imaging are also contributing to the dominance of diagnostic applications. Modern imaging systems, such as digital mammography and breast tomosynthesis, allow healthcare professionals to obtain highly detailed images, improving lesion detection and reducing diagnostic uncertainty. These technologies enhance clinical decision-making and support more precise patient management.

Collectively, the growing prevalence of breast cancer, advancements in imaging technology, and the critical role of confirmatory diagnostics have positioned diagnostic mammography as the dominant application segment in the UAE mammography market.

Gain a Competitive Edge with Our UAE Mammography Market Report:

• UAE Mammography Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
• UAE Mammography Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.